SatoTNakamuraHFujiedaY, et al.
Factor Xa inhibitors for preventing recurrent thrombosis in patients with antiphospholipid syndrome: a longitudinal cohort study. Lupus2019;
28: 1577–1582.
2.
PengoVDenasGZoppellaroG, et al.
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome. Blood2018;
132: 1365–1371.
3.
DufrostVRisseJReshetnyakT, et al.
Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis. Autoimmun Rev2018;
17: 1011–1021.
4.
ElsebaieMATVan EsNLangstonABüllerHRGaddhM.Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta-analysis. J Thromb Haemost2019;
17: 645–656.
